Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 446292-04-2 | MDL No. : | MFCD08236741 |
Formula : | C10H10N2O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | OWMGEFWSGOTGAU-UHFFFAOYSA-N |
M.W : | 222.20 | Pubchem ID : | 11447375 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.3 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 61.19 |
TPSA : | 75.36 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.11 cm/s |
Log Po/w (iLOGP) : | 1.62 |
Log Po/w (XLOGP3) : | 0.77 |
Log Po/w (WLOGP) : | 0.58 |
Log Po/w (MLOGP) : | 0.66 |
Log Po/w (SILICOS-IT) : | -0.59 |
Consensus Log Po/w : | 0.61 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.85 |
Solubility : | 3.15 mg/ml ; 0.0142 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.93 |
Solubility : | 2.59 mg/ml ; 0.0117 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.86 |
Solubility : | 3.07 mg/ml ; 0.0138 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.91 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 438056-69-0 ]
4-(4-Aminophenyl)morpholin-3-one
Similarity: 0.79
[ 503615-03-0 ]
3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one
Similarity: 0.78
[ 38560-30-4 ]
1-(4-Nitrophenyl)piperidin-2-one
Similarity: 0.71
[ 438056-69-0 ]
4-(4-Aminophenyl)morpholin-3-one
Similarity: 0.79
[ 503615-03-0 ]
3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one
Similarity: 0.78
[ 38560-30-4 ]
1-(4-Nitrophenyl)piperidin-2-one
Similarity: 0.71
[ 503615-03-0 ]
3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one
Similarity: 0.78
[ 38560-30-4 ]
1-(4-Nitrophenyl)piperidin-2-one
Similarity: 0.71
[ 5521-38-0 ]
2-(4-(4-Nitrophenyl)piperazin-1-yl)ethanol
Similarity: 0.71
[ 438056-69-0 ]
4-(4-Aminophenyl)morpholin-3-one
Similarity: 0.79
[ 38560-30-4 ]
1-(4-Nitrophenyl)piperidin-2-one
Similarity: 0.71
[ 5521-38-0 ]
2-(4-(4-Nitrophenyl)piperazin-1-yl)ethanol
Similarity: 0.71
[ 112559-81-6 ]
4-(4-(4-Nitrophenyl)-1-piperazinyl)phenol
Similarity: 0.65
[ 438056-69-0 ]
4-(4-Aminophenyl)morpholin-3-one
Similarity: 0.79
[ 503615-03-0 ]
3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one
Similarity: 0.78
[ 404010-98-6 ]
4-Morpholin-4-yl-2-nitrobenzoic acid
Similarity: 0.68